| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/27/2005 | WO2005007875A2 Enhanced promoters for synthesis of small hairpin rna |
| 01/27/2005 | WO2005007874A2 Sequential generation of multiple chemiluminescent signals on solid supports |
| 01/27/2005 | WO2005007868A2 Controlled platelet activation to monitor therapy of adp antagonists |
| 01/27/2005 | WO2005007866A2 Biochip devices for ion transport measurement, methods of manufacture, and methods of use |
| 01/27/2005 | WO2005007846A1 Method of judging senstivity of tumor cell to anticancer agent |
| 01/27/2005 | WO2005007844A1 Method of screening for agents that modulate immunophilin/peptidylproline cis-trans isomerase (ppiase)-homer interaction |
| 01/27/2005 | WO2005007836A1 Regulatory t-cells containing galectins for the therapy and diagnosis of diseases |
| 01/27/2005 | WO2005007822A2 Method for assaying protein-protein interaction |
| 01/27/2005 | WO2005007821A2 Tertiary structures of ica-1/lfa-1 modulators |
| 01/27/2005 | WO2005007744A1 Methods and systems for creating and using comprehensive and data-driven simulations of complex biological systems for pharmacological and industrial applications |
| 01/27/2005 | WO2005007698A1 Monoclonal antibody against influenza b virus and immunoassay instrument using the antibody |
| 01/27/2005 | WO2005007692A1 Antibodies that recognize the brms1 protein and uses thereof |
| 01/27/2005 | WO2005007691A2 East coast fever vaccine based on ctl-specific schizont antigens |
| 01/27/2005 | WO2005007688A2 Human prostaglandin fp receptor variants and methods of using same |
| 01/27/2005 | WO2005007677A2 Affinity capture of peptides by microarray and related methods |
| 01/27/2005 | WO2005007646A1 Substituted heterocyclic diarylamine analogues |
| 01/27/2005 | WO2005007282A2 Storage and use of colloids |
| 01/27/2005 | WO2005007198A2 Design of disease specific agents for diagnostics and therapeutics based on the protein isoform of vegf, her-2, psa |
| 01/27/2005 | WO2005007186A1 Treatment and diagnosis of neoplasms using thymic stromal lymphopoietin |
| 01/27/2005 | WO2005007116A2 Artificial antigen presenting cell devices |
| 01/27/2005 | WO2005007108A2 Asymmetric disulfides and methods of using same |
| 01/27/2005 | WO2005007097A2 Breast cancer genes |
| 01/27/2005 | WO2005007090A2 Inhibitors of the map kinase pathway |
| 01/27/2005 | WO2005006985A2 Analysis apparatus and analysis method for body fluids |
| 01/27/2005 | WO2005006981A1 Sensoric method for evaluating breath |
| 01/27/2005 | WO2005006960A2 Detection of cell membrane-associated proteins using membrane fragments displayed on encoded microparticle arrays |
| 01/27/2005 | WO2005006959A2 Compact analyte testing cassette with true positive and negative analyte controls |
| 01/27/2005 | WO2005006949A2 Methods for predicting development of auto-immune diseases and treatment of same |
| 01/27/2005 | WO2005006849A1 Method and apparatus for indicating a health condition of a milking animal |
| 01/27/2005 | WO2004113900A3 Test strip with flared sample receiving chamber |
| 01/27/2005 | WO2004109279A3 Sensitive and selective in vitro assay for the detection of reactive drug intermediates |
| 01/27/2005 | WO2004108754A3 Herpes simplex virus us11 protein and hipk2 protein complexes and uses thereof |
| 01/27/2005 | WO2004105785A3 Use of pam |
| 01/27/2005 | WO2004104575A3 Diagnostics and therapeutics for diseases associated with x-prolyl aminopeptidase 2 (xpnpep2) |
| 01/27/2005 | WO2004102198A3 Selection of b cells with specificity of interest: method of preparation and use |
| 01/27/2005 | WO2004102159A3 Quantum mechanics based method for scoring protein-ligand interactions |
| 01/27/2005 | WO2004099444A3 Diagnostic methods |
| 01/27/2005 | WO2004099424A3 Enrichment of enzymatic cleavage products |
| 01/27/2005 | WO2004094460A3 Polypeptides related to natriuretic peptides and methods of their identification and use |
| 01/27/2005 | WO2004091481A3 Methods and kits for detecting cerebrospinal fluid in a sample |
| 01/27/2005 | WO2004082575A3 Diagnostics and therapeutics for diseases associated with phosphodiesterase 6b (pde6b) |
| 01/27/2005 | WO2004082570A3 Diagnostics and therapeutics for diseases associated with dopamine receptor d2 (drd2) |
| 01/27/2005 | WO2004082517A3 Animal exhibiting ptsd-like behavior, per pct rule 4.3 |
| 01/27/2005 | WO2004081534A3 Phosphokinase assay |
| 01/27/2005 | WO2004081530A3 Method and apparatus for environmental monitoring and bioprospecting |
| 01/27/2005 | WO2004080424A3 Methods and compositions for neurite outgrowth detection |
| 01/27/2005 | WO2004074762A3 System for characterizing bulk mechanical properties of aerated materials |
| 01/27/2005 | WO2004074514A3 Method of diagnosis of type 2 diabetes and early onset thereof |
| 01/27/2005 | WO2004074325A3 Compositions and methods for the detection and treatment of methylthioadenosine phosphorylase deficient cancers |
| 01/27/2005 | WO2004072232A3 Covalent tethering of functional groups to proteins |
| 01/27/2005 | WO2004071459A3 Methods and compositions related to irm compounds and toll-like receptor 8 |
| 01/27/2005 | WO2004071345A3 A device and method for the determination of lithium ion concentration in a biological fluid |
| 01/27/2005 | WO2004070382A3 Biosensor, method for the production thereof, and measuring apparatus and method for biological samples |
| 01/27/2005 | WO2004064972A3 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| 01/27/2005 | WO2004064740A3 Sperm specific lysozyme-like proteins |
| 01/27/2005 | WO2004063717A3 Gyratory compactor apparatus and associated devices and methods |
| 01/27/2005 | WO2004062553A3 Affinity screening using “one-bead-one-compound” libraries |
| 01/27/2005 | WO2004060053A3 Transgenic mice expressing human cd20 |
| 01/27/2005 | WO2004053929A3 Semiconductor nanocrystal heterostructures |
| 01/27/2005 | WO2004053497A3 Method for predicting the response to her2-directed therapy |
| 01/27/2005 | WO2004050851A3 Prion protein ligands and methods of use |
| 01/27/2005 | WO2004046720A3 Methods for identifying members of specific binding pairs |
| 01/27/2005 | WO2004031730A3 High sensitivity quantitation of peptides by mass spectrometry |
| 01/27/2005 | WO2004025254B1 Food-borne pathogen and spoilage detection device and method |
| 01/27/2005 | WO2004024756A3 Orthopoxvirus antigens and use thereof |
| 01/27/2005 | WO2004010100A3 Meta-models for predicting blood brain barrier penetration based on physicochemical descriptors, like h-bond donors/acceptors and partition coefficients |
| 01/27/2005 | WO2004005882A3 Multi-parameter high throughput screening assays (mphts) |
| 01/27/2005 | WO2003078960A3 Analysis of sulfated polysaccharides |
| 01/27/2005 | WO2003072600A3 Methods of screening molecular libraries for active molecules that restore the function of target proteins and peptides that restore the function of mutant p53 |
| 01/27/2005 | WO2002087554B1 Ef-tu binding agent as antibacterial agent |
| 01/27/2005 | WO2002042417A3 Human erg2 potassium channel |
| 01/27/2005 | US20050022264 Method and a device for determination of the actual photosynthesis in plants |
| 01/27/2005 | US20050022256 Triple transgenic mouse model of alzheimer's disease |
| 01/27/2005 | US20050021495 System and method for tracking environmental emission reductions |
| 01/27/2005 | US20050021285 Method of determining a dimension of a sample of a construction material and associated apparatus |
| 01/27/2005 | US20050021262 Quality and condition monitoring based on spectrum separating measurement |
| 01/27/2005 | US20050021241 Gain of function sorting for drug discovery and development |
| 01/27/2005 | US20050021240 Systems, methods and computer program products for guiding selection of a therapeutic treatment regimen based on the methylation status of the DNA |
| 01/27/2005 | US20050021239 Interpretation |
| 01/27/2005 | US20050021238 Method and system for chromosome correction in genetic optimazation process |
| 01/27/2005 | US20050021237 Method and apparatus for evaluating new chemical entities |
| 01/27/2005 | US20050021236 Statistically identifying an increased risk for disease |
| 01/27/2005 | US20050021235 Method and system for optically performing an assay to determine a medical condition |
| 01/27/2005 | US20050021216 Detecting soot during real time operation in diesel engine lubricant |
| 01/27/2005 | US20050021066 Analytical device with lancet and test element |
| 01/27/2005 | US20050020937 Method for detecting pathogenic agents |
| 01/27/2005 | US20050020931 Management of gastro-intestinal disorders |
| 01/27/2005 | US20050020923 Materials and methods for near-infrared and infrared lymph node mapping |
| 01/27/2005 | US20050020907 Method and apparatus of slice selective magnetization preparation for moving table mri |
| 01/27/2005 | US20050020812 A chromatography media such as silica controlled pore glass or agarose containing an affinity ligand such as 2-Aminobenzimidazole (ABI) or aminomethylbenzimidazole (AMBI); great degree of selectivity, particularly towards proteins such as IgG |
| 01/27/2005 | US20050020667 Compounds and therapies for the prevention of vascular and non-vascular pathologies |
| 01/27/2005 | US20050020646 Treating the lower urinary tract symptoms associated with BPH with an antagonist for EP1 receptors, for example, ONO-8711, ONO-8713, 3-{3-[5-chloro-2-(phenylmethoxy)phenyl]2-thienyl}benzoic acid or SC-51089 |
| 01/27/2005 | US20050020547 Compounds for the treatment of female sexual dysfunction |
| 01/27/2005 | US20050020519 Increase concentration of peptide; controlling glucose uptake into cells; adjust metabolism; stimulate cell proliferation; reduce apoptosis; moderate gene expression' |
| 01/27/2005 | US20050020496 Diagnosis, hormone replacement therapy for HIV positive females, gene therapy; metabolic disorders; antidiabetic, anticholesterol, hypoglycemic agents |
| 01/27/2005 | US20050020482 Methods for modulating gap junctions |
| 01/27/2005 | US20050019958 Monitoring tricyclic terpene binding activity to neuronal membrane protein for use as tool in identifying modulators of pain perception |
| 01/27/2005 | US20050019957 Breaking up the leukocytes in a blood sample by contacting blood sample with the following aqueous liquid or an aqueous liquid mixture; immunologically determining the amount of human medullasin released into blood sample; diagnosing multiple sclerosis from the results obtained by comparing |
| 01/27/2005 | US20050019956 Microfluidic apparatus comprising immobilized ligands for use in monitoring protein binding; kinetic binding assay; biosensor |
| 01/27/2005 | US20050019955 comprises a luminescent color center in which a nitrogen heteroatom is substitutionally positioned on a diamondoid lattice site adjacent to a vacancy or pore; emits a characteristic spectrum which can be observed and measured |